v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]    
Net sales $ 2,403 $ 1,904
Cost of goods sold 719 837
Gross profit 1,684 1,067
Operating expenses:    
Selling, general and administrative 4,524 3,577
Research and development 1,728 550
Total operating expenses 6,252 4,127
Loss from operations (4,568) (3,060)
Other income 1 7
Change in fair value of warrant liabilities 26 40
Loss before income taxes (4,541) (3,013)
Income tax expense 0 (1)
Net loss (4,541) (3,014)
Deemed dividend attributable to Series J Convertible Preferred Stock 2 1
Net loss attributable to common shareholders $ (4,539) $ (3,013)
Basic loss per share (in Dollars per share) $ (2.19) $ (28.93)
Diluted loss per share (in Dollars per share) $ (2.19) $ (28.93)
Weighted average shares outstanding – basic (in Shares) 2,074,940 104,142
Weighted average shares outstanding – diluted (in Shares) 2,074,940 104,142
Other comprehensive loss:    
Net loss $ (4,541) $ (3,014)
Foreign currency translation adjustments 0 (2)
Total comprehensive loss $ (4,541) $ (3,016)